EP3052476
Setnir nikótínimíð hemlar BTK og framleiðsla þeirra og notkun við meðferð krabbameins, bólgu og sjálfnæmissjúkdóms
:
EP einkaleyfi í gildi á Íslandi:
29.9.2014:
15.7.2020:
14848083.3
:
9.9.2020:
15.10.2020
:
28.9.2034:
28.9.2025:
30.9.2025
:
SUBSTITUTED NICOTINIMIDE INHIBITORS OF BTK AND THEIR PREPARATION AND USE IN THE TREATMENT OF CANCER, INFLAMMATION AND AUTOIMMUNE DISEASE
29.9.2014
15.7.2020
9.9.2020
15.10.2020
28.9.2025
:
Guangzhou InnoCare Pharma Tech Co., Ltd.:
Room 899 No. 333 Jiufo Jianshe Road, Sino-Singapore Guangzhou Knowledge City Guangzhou Guangdong 510130, CN
:
CHEN, Xiangyang:
Changping District Beijing 102206, CN
:
GAO, Yingxiang:
Changping District Beijing 102206, CN
:
LIU, Chong:
Shanghai 200131, CN
:
NI, Haihong:
Shanghai 200131, CN
:
MULVIHILL, Mark:
Waltham, MA 02453, US
:
Patice ehf.:
Pósthólf 8236, 128, Reykjavík,
:
201361884958 P:
30.9.2013:
US
:
201310485048:
16.10.2013:
CN
:
US2014058084:
29.9.2014
:
C07D 213/81, C07D 213/84, C07D 231/36, C07D 277/56, C07D 263/34, C07D 401/14, C07D 401/04, C07D 401/12, C07C 233/65, A61K 31/4418, A61K 31/4427, A61K 31/415, A61K 31/4155, A61K 31/426, A61K 31/421, A61K 31/4468, A61K 31/166, A61P 35/00, C07D 239/47, A61K 31/505
: 7
: 22.9.2020
: 28.9.2021
: Patice ehf.
: 8
: 21.9.2021
: 28.9.2022
: Árnason Faktor ehf.
: 9
: 27.9.2022
: 28.9.2023
: Árnason Faktor ehf.
: 10
: 28.9.2023
: 28.9.2024
: Árnason Faktor ehf.
: 11
: 19.8.2024
: 28.9.2025
: Acumass